Literature DB >> 7809078

Altered striatal function in a mutant mouse lacking D1A dopamine receptors.

J Drago1, C R Gerfen, J E Lachowicz, H Steiner, T R Hollon, P E Love, G T Ooi, A Grinberg, E J Lee, S P Huang.   

Abstract

Of the five known dopamine receptors, D1A and D2 represent the major subtypes expressed in the striatum of the adult brain. Within the striatum, these two subtypes are differentially distributed in the two main neuronal populations that provide direct and indirect pathways between the striatum and the output nuclei of the basal ganglia. Movement disorders, including Parkinson disease and various dystonias, are thought to result from imbalanced activity in these pathways. Dopamine regulates movement through its differential effects on D1A receptors expressed by direct output neurons and D2 receptors expressed by indirect output neurons. To further examine the interaction of D1A and D2 neuronal pathways in the striatum, we used homologous recombination to generate mutant mice lacking functional D1A receptors (D1A-/-). D1A-/- mutants are growth retarded and die shortly after weaning age unless their diet is supplemented with hydrated food. With such treatment the mice gain weight and survive to adulthood. Neurologically, D1A-/- mice exhibit normal coordination and locomotion, although they display a significant decrease in rearing behavior. Examination of the striatum revealed changes associated with the altered phenotype of these mutants. D1A receptor binding was absent in striatal sections from D1A-/- mice. Striatal neurons normally expressing functional D1A receptors are formed and persist in adult homozygous mutants. Moreover, substance P mRNA, which is colocalized specifically in striatal neurons with D1A receptors, is expressed at a reduced level. In contrast, levels of enkephalin mRNA, which is expressed in striatal neurons with D2 receptors, are unaffected. These findings show that D1A-/- mice exhibit selective functional alterations in the striatal neurons giving rise to the direct striatal output pathway.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7809078      PMCID: PMC45479          DOI: 10.1073/pnas.91.26.12564

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  39 in total

1.  Topographic nonoverlapping distribution of D1 and D2 dopamine receptors in the amygdaloid nuclear complex of the rat brain.

Authors:  R J Scibilia; J E Lachowicz; C D Kilts
Journal:  Synapse       Date:  1992-06       Impact factor: 2.562

2.  Adipsia and aphagia after 6-hydroxydopamine induced degeneration of the nigro-striatal dopamine system.

Authors:  U Ungerstedt
Journal:  Acta Physiol Scand Suppl       Date:  1971

3.  Expression of dopamine D1A receptor gene in proximal tubule of rat kidneys.

Authors:  I Yamaguchi; P A Jose; M M Mouradian; L M Canessa; F J Monsma; D R Sibley; K Takeyasu; R A Felder
Journal:  Am J Physiol       Date:  1993-02

4.  Effects of dopamine D1 antagonists SCH23390 and SK&F83566 on locomotor activities in rats.

Authors:  M E Meyer; G A Cottrell; C Van Hartesveldt; T J Potter
Journal:  Pharmacol Biochem Behav       Date:  1993-02       Impact factor: 3.533

5.  Locomotor activity following intra-accumbens microinjections of dopamine D1 agonist SK&F 38393 in rats.

Authors:  M E Meyer; C Van Hartesveldt; T J Potter
Journal:  Synapse       Date:  1993-04       Impact factor: 2.562

6.  Targeted mutation of the DNA methyltransferase gene results in embryonic lethality.

Authors:  E Li; T H Bestor; R Jaenisch
Journal:  Cell       Date:  1992-06-12       Impact factor: 41.582

7.  D1 and D2 dopamine receptors differentially regulate c-fos expression in striatonigral and striatopallidal neurons.

Authors:  G S Robertson; S R Vincent; H C Fibiger
Journal:  Neuroscience       Date:  1992-07       Impact factor: 3.590

8.  Cocaine-induced c-fos messenger RNA is inversely related to dynorphin expression in striatum.

Authors:  H Steiner; C R Gerfen
Journal:  J Neurosci       Date:  1993-12       Impact factor: 6.167

9.  Localization of D1 and D2 dopamine receptors in brain with subtype-specific antibodies.

Authors:  A I Levey; S M Hersch; D B Rye; R K Sunahara; H B Niznik; C A Kitt; D L Price; R Maggio; M R Brann; B J Ciliax
Journal:  Proc Natl Acad Sci U S A       Date:  1993-10-01       Impact factor: 11.205

10.  Cellular localization and regulation of gene expression for components of the insulin-like growth factor ternary binding protein complex.

Authors:  E Chin; J Zhou; J Dai; R C Baxter; C A Bondy
Journal:  Endocrinology       Date:  1994-06       Impact factor: 4.736

View more
  96 in total

1.  Dopamine D1 and D3 receptors are differentially involved in cue-elicited cocaine seeking.

Authors:  Liping Chen; Ming Xu
Journal:  J Neurochem       Date:  2010-04-28       Impact factor: 5.372

2.  Essential conservation of D1 mutant phenotype at the level of individual topographies of behaviour in mice lacking both D1 and D3 dopamine receptors.

Authors:  John Y F Wong; Jeremiah J Clifford; Jim S Massalas; Anthony Kinsella; John L Waddington; John Drago
Journal:  Psychopharmacology (Berl)       Date:  2003-03-22       Impact factor: 4.530

3.  Genetic evidence for the bidirectional modulation of synaptic plasticity in the prefrontal cortex by D1 receptors.

Authors:  Yan-You Huang; Eleanor Simpson; Christoph Kellendonk; Eric R Kandel
Journal:  Proc Natl Acad Sci U S A       Date:  2004-02-23       Impact factor: 11.205

4.  New operant model of reinstatement of food-seeking behavior in mice.

Authors:  Elena Martín-García; Aurelijus Burokas; Elzbieta Kostrzewa; Agnieszka Gieryk; Michal Korostynski; Barbara Ziolkowska; Barbara Przewlocka; Ryszard Przewlocki; Rafael Maldonado
Journal:  Psychopharmacology (Berl)       Date:  2010-12-14       Impact factor: 4.530

Review 5.  Advancing schizophrenia drug discovery: optimizing rodent models to bridge the translational gap.

Authors:  Judith Pratt; Catherine Winchester; Neil Dawson; Brian Morris
Journal:  Nat Rev Drug Discov       Date:  2012-06-22       Impact factor: 84.694

6.  Essential role of D1R in the regulation of mTOR complex1 signaling induced by cocaine.

Authors:  Laurie P Sutton; Marc G Caron
Journal:  Neuropharmacology       Date:  2015-08-24       Impact factor: 5.250

Review 7.  Phenotypic studies on dopamine receptor subtype and associated signal transduction mutants: insights and challenges from 10 years at the psychopharmacology-molecular biology interface.

Authors:  John L Waddington; Colm O'Tuathaigh; Gerard O'Sullivan; Katsunori Tomiyama; Noriaki Koshikawa; David T Croke
Journal:  Psychopharmacology (Berl)       Date:  2005-09-29       Impact factor: 4.530

8.  Low affinity binding of the classical D1 antagonist SCH23390 in rodent brain: potential interaction with A2A and D2-like receptors.

Authors:  Sarah K Leonard; Penelope Ferry-Leeper; Richard B Mailman
Journal:  Brain Res       Date:  2006-09-07       Impact factor: 3.252

9.  Targeted expression of a toxin gene to D1 dopamine receptor neurons by cre-mediated site-specific recombination.

Authors:  J Drago; P Padungchaichot; J Y Wong; A J Lawrence; J F McManus; S H Sumarsono; A L Natoli; M Lakso; N Wreford; H Westphal; I Kola; D I Finkelstein
Journal:  J Neurosci       Date:  1998-12-01       Impact factor: 6.167

Review 10.  Modeling the positive symptoms of schizophrenia in genetically modified mice: pharmacology and methodology aspects.

Authors:  Maarten van den Buuse
Journal:  Schizophr Bull       Date:  2009-11-09       Impact factor: 9.306

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.